CS
Publications
276
Views
145,700
Downloads
24,935
Supervised works
15
Items per page
1 - 276 of 276
Title Published in Access level OA Policy Year Views Downloads
Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North AmericaFrontiers in immunology
accessLevelPublic
2024 193 102
Influence of timing of maternal pertussis immunization on the avidity of transferred antibodies in term and preterm neonatesClinical infectious diseases
accessLevelPublic
2023 72 75
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents : 5-year durabilityClinical microbiology and infection
accessLevelRestricted
2023 103 0
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19Frontiers in immunology
accessLevelPublic
2023 187 39
Influence of circadian clocks on adaptive immunity and vaccination responsesNature communications
accessLevelPublic
2023 292 69
C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonatesFrontiers in immunology
accessLevelPublic
2023 115 63
Omicron-specific cytotoxic t-cell responses after a third dose of mrna covid-19 vaccine among patients with multiple sclerosis treated with ocrelizumabJAMA neurology
accessLevelPublic
2022 232 139
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 yearsScientific reports
accessLevelPublic
2022 107 15
Swiss recommendations on perioperative antimicrobial prophylaxis in childrenSwiss medical weekly
accessLevelPublic
2022 91 24
Transcriptomic signatures induced by the Ebola virus vaccine rVSV?G-ZEBOV-GP in adult cohorts in Europe, Africa, and North America : a molecular biomarker studyThe Lancet microbe
accessLevelPublic
2022 167 52
Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controlsVaccine
accessLevelRestricted
2022 59 0
Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence90th EAS (European Atherosclerosis Society) Congress
2022 79 0
Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort StudyClinical infectious diseases
accessLevelPublic
2022 211 31
Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistenceEuropean journal of clinical investigation
accessLevelPublic
2022 424 118
Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosisInternational journal of molecular sciences
accessLevelPublic
2022 253 127
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCsNature communications
accessLevelPublic
2022 275 144
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive AnalysisFrontiers in immunology
accessLevelPublic
2022 190 125
Is there a role for childhood vaccination against COVID-19?Pediatric allergy and immunology
accessLevelRestricted
2021 265 1
Human Transcriptomic Response to the VSV-Vectored Ebola VaccineVaccines
accessLevelPublic
2021 139 63
SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1EAS Congress 2021
2021 356 38
Rabies vaccination and multiple sclerosis relapse: A retrospective cohort studyMultiple Sclerosis and Related Disorders
accessLevelPublic
2021 326 128
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunityCell reports
accessLevelPublic
2021 420 231
Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infectionClinical Microbiology and Infection
accessLevelPublic
2021 514 299
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of SymptomsJournal of clinical immunology
accessLevelPublic
2021 294 110
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal studyClinical Microbiology and Infection
accessLevelPublic
2021 387 194
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1European Journal of Clinical Investigation
accessLevelPublic
2021 395 239
Risk of Vaccine-Preventable Infections in Swiss Adults with Inflammatory Bowel DiseaseDigestion
accessLevelPublic
2021 130 53
Faudra-t-il vacciner les enfants contre le Covid-19 ?Revue médicale suisse
accessLevelPublic
2021 71 43
Pneumococcal immunity and PCV13 vaccine response in SOT-candidates and recipientsVaccine
accessLevelRestricted
2021 208 0
Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settingsJournal of Clinical Medicine
accessLevelPublic
2021 332 156
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccinationNPJ Vaccines
accessLevelPublic
2020 464 110
Validation of a commercially available SARS-CoV-2 serological immunoassayClinical Microbiology and Infection
accessLevelPublic
2020 503 279
Diagnostic accuracy of Augurix COVID-19 IgG serology rapid testEuropean Journal of Clinical Investigation
accessLevelPublic
2020 444 373
Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid testsJournal of Clinical Medicine
accessLevelPublic
2020 371 183
Risk of MS relapse after yellow fever vaccination: A self-controlled case seriesNeurology: Neuroimmunology & Neuroinflammation
accessLevelPublic
2020 239 83
A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent MannerFrontiers in immunology
accessLevelPublic
2020 255 137
Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trialClinical Microbiology and Infection
accessLevelPublic
2020 313 167
Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case seriesmSphere
accessLevelPublic
2020 511 192
Missed vaccinations and critical care admission: all you may wish to know or rediscover-a narrative reviewIntensive Care Medicine
accessLevelRestricted
2020 482 0
High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology
accessLevelRestricted
2019 290 0
Long-term Seroprotection of Varicella-zoster Immunization in Pediatric Liver Transplant RecipientsTransplantation
accessLevelRestricted
2019 414 1
Maternal antibodies inhibit neonatal and infant responses to vaccination by shaping the early-life B cell repertoire within germinal centersCell Reports
accessLevelPublic
2019 311 183
Detectable Vesicular Stomatitis Virus (VSV)-specific humoral and cellular immune responses following VSV-Ebola virus vaccination in humansThe Journal of Infectious Diseases
accessLevelPublic
2019 227 149
Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort studyRheumatology
accessLevelRestricted
2019 297 0
Usefulness of a systematic approach at listing for vaccine prevention in solid organ transplant candidatesAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
accessLevelRestricted
2019 438 3
Neonatal T follicular helper cells are lodged in a pre-T follicular helper stage favoring innate over adaptive germinal center responsesFrontiers in Immunology
accessLevelPublic
2019 331 171
Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantationAmerican Journal of Transplantation
accessLevelRestricted
2019 511 4
Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical TrialClinical Infectious Diseases
accessLevelPublic
2019 300 286
Site-specific DC surface signatures influence CD4+ T cell co-stimulation and lung-homingFrontiers in Immunology
accessLevelPublic
2019 282 153
Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including FormulationFrontiers in Immunology
accessLevelPublic
2019 265 146
Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland's largest pre-trial prisonJournal of Global Health
accessLevelPublic
2018 415 197
Overcoming the neonatal limitations of inducing germinal centers through liposome-based adjuvants including c-type lectin agonists trehalose dibehenate or curdlanFrontiers in Immunology
accessLevelPublic
2018 485 423
Prévention de la grippe en milieu de soins aigus : une intervention multimodaleRevue médicale suisse
accessLevelPublic
2018 456 205
Correlates of vaccine-induced protective immunity against Ebola virus diseaseSeminars in Immunology
accessLevelPublic
2018 651 266
Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccinationNPJ Vaccines
accessLevelPublic
2018 408 154
Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein 180L Single-Nucleotide Polymorphism Is Associated With Susceptibility to Recurrent Pneumococcal Lower Respiratory Tract Infections in ChildrenFrontiers in Immunology
accessLevelPublic
2018 522 229
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort studyThe Lancet Infectious Diseases
accessLevelRestricted
2018 500 0
Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?Expert Review of Vaccines
accessLevelPrivate
2018 359 0
A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and AfricaScience Translational Medicine
accessLevelRestricted
2017 618 2
Pertussis Antibody Transfer to Preterm Neonates After Second- Versus Third-Trimester Maternal ImmunizationClinical Infectious Diseases
accessLevelPublic
2017 614 243
Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous surveyPLOS ONE
accessLevelPublic
2017 494 192
Antenatal vaccination to decrease pertussis in infants: safety, effectiveness, timing, and implementationThe Journal of Maternal - Fetal & Neonatal Medicine
accessLevelRestricted
2017 454 0
Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussisClinical infectious diseases
accessLevelRestricted
2016 735 5
Clinical Management of Ebola Virus Disease in the United States and EuropeNew England Journal of Medicine
accessLevelPublic
2016 1,206 340
Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhoodProceedings of the National Academy of Sciences of the United States of America
accessLevelRestricted
2016 645 2
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary ReportThe New England journal of medicine
accessLevelPublic
2016 904 262
Reply to Abu Raya et alClinical infectious diseases
accessLevelRestricted
2016 429 3
Vaccination in early life: standing up to the challengesCurrent Opinion in Immunology
accessLevelRestricted
2016 495 1
IL-36-Induced Toxicity in Neonatal Mice Involves TNF-α Production by Liver Myeloid CellsJournal of Immunology
accessLevelRestricted
2016 538 2
Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genesThe Journal of experimental medicine
accessLevelRestricted
2016 765 4
The 2014–2015 Ebola outbreak in West Africa: Hands OnAntimicrobial Resistance and Infection Control
accessLevelPublic
2016 526 226
Optimizing seroprotection against pneumococcus in children with nephrotic syndrome using the 13-valent pneumococcal conjugate vaccineVaccine
accessLevelRestricted
2016 575 3
Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I studyVaccine
accessLevelRestricted
2015 517 0
The Nucleoprotein Is Required for Lymphocytic Choriomeningitis Virus-Based Vaccine Vector ImmunogenicityJournal of virology
accessLevelRestricted
2015 584 2
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialLancet. Infectious diseases
accessLevelRestricted
2015 683 0
Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseasesSchweizerische medizinische Wochenschrift
accessLevelRestricted
2015 608 1
Protective efficacy of individual CD8+ T cell specificities in chronic viral infectionThe Journal of immunology
accessLevelRestricted
2015 619 0
Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case reportLancet. Infectious diseases
accessLevelRestricted
2015 699 1
Ebola vaccine R&D: Filling the knowledge gapsScience translational medicine
accessLevelRestricted
2015 501 1
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early LifeThe Journal of immunology
accessLevelRestricted
2015 661 2
Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of conceptVaccine
accessLevelPublic
2015 605 168
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted InfectionPLOS pathogens
accessLevelPublic
2015 701 290
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases--a longitudinal studyArthritis research & therapy
accessLevelPublic
2015 532 468
Bordetella holmesii: an under-recognised Bordetella speciesLancet. Infectious diseases
accessLevelRestricted
2014 718 0
Diagnosis of whooping cough in Switzerland: differentiating Bordetella pertussis from Bordetella holmesii by polymerase chain reactionPloS one
accessLevelPublic
2014 745 326
Influence of age, social patterns and nasopharyngeal carriage on antibodies to three conserved pneumococcal surface proteins (PhtD, PcpA and PrtA) in healthy young childrenEuropean journal of clinical microbiology & infectious diseases
accessLevelPublic
2013 683 289
Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in childrenThe Pediatric infectious disease journal
accessLevelRestricted
2013 614 0
Memory B cell compartment constitution and susceptibility to recurrent lower respiratory tract infections in young childrenJournal of leukocyte biology
accessLevelRestricted
2013 767 0
Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newbornThe Pediatric infectious disease journal
accessLevelRestricted
2013 713 3
Tetanus immunity as a surrogate for past diphtheria-tetanus-pertussis immunization in migrant childrenThe Pediatric infectious disease journal
accessLevelRestricted
2013 701 5
Functional limitations of plasmacytoid dendritic cells limit type I interferon, T cell responses and virus control in early lifePloS one
accessLevelPublic
2013 703 384
Calendrier vaccinal InfoVac pratique 2013Archives de pédiatrie
accessLevelRestricted
2013 641 6
Homing and adhesion patterns determine the cellular composition of the bone marrow plasma cell nicheThe Journal of immunology
accessLevelRestricted
2012 596 0
Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccineAntiviral therapy
accessLevelRestricted
2012 633 6
Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity*HIV medicine
accessLevelRestricted
2012 603 1
Use of pneumococcal polysaccharide vaccine in children: what is the evidence?Current opinion in infectious diseases
accessLevelRestricted
2012 542 0
Determinants of hepatitis A vaccine immunity in a cohort of human immunodeficiency virus-infected children living in SwitzerlandClinical and vaccine immunology
accessLevelRestricted
2012 657 0
Comparison of clinical presentation of respiratory tract infections in H1N1/09-positive and H1N1/09-negative patientsEuropean journal of pediatrics
accessLevelPublic
2012 697 268
Bulletin InfoVac-FranceArchives de pédiatrie
accessLevelRestricted
2012 541 0
Bulletin InfoVac-FranceArchives de pédiatrie
accessLevelRestricted
2012 566 0
Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccinePloS one
accessLevelPublic
2012 758 323
Failure to elicit seroresponses to pneumococcal surface proteins (pneumococcal histidine triad D, pneumococcal choline-binding protein A, and serine proteinase precursor A) in children with pneumococcal bacteraemiaClinical microbiology and infection
accessLevelRestricted
2012 581 0
Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenicAmerican journal of transplantation
accessLevelRestricted
2012 781 1
Acceptability of maternal immunization against influenza: the critical role of obstetriciansJournal of maternal-fetal & neonatal medicine
accessLevelRestricted
2012 718 0
Vaccination against seasonal flu in Switzerland: The indecision of pregnant women encouraged by healthcare professionalsRevue d'épidémiologie et de santé publique
accessLevelRestricted
2012 713 3
Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvantsThe Journal of immunology
accessLevelRestricted
2012 598 0
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patientsHIV medicine
accessLevelRestricted
2012 710 0
Bulletin InfoVac-FranceArchives de pédiatrie
accessLevelRestricted
2012 573 0
Successful serology-based intervention to increase protection against vaccine-preventable diseases in liver-transplanted children: a 19-yr review of the Swiss national reference centerPediatric transplantation
accessLevelRestricted
2012 687 0
A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analogJournal of controlled release
accessLevelRestricted
2012 657 1
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatientsThe oncologist
accessLevelRestricted
2012 682 0
Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responsesThe Journal of immunology
accessLevelRestricted
2012 688 0
Protective antibody responses to influenza A/H1N1/09 vaccination in children with celiac diseaseJournal of pediatric gastroenterology and nutrition
accessLevelPublic
2012 626 439
Vaccinologie : nouvelles recommandations pour les rappels tétanos, diphtérie et coqueluche chez l'adulteRevue médicale suisse
accessLevelRestricted
2012 586 2
Health problems most commonly diagnosed among young female patients during visits to general practitioners and gynecologists in France before the initiation of the human papillomavirus vaccination programPharmacoepidemiology and drug safety
accessLevelRestricted
2012 610 1
Bulletin spécial calendrier vaccinalArchives de pédiatrie
accessLevelRestricted
2011 500 2
Bulletin InfoVac-FranceArchives de pédiatrie
accessLevelRestricted
2011 545 0
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipientsHaematologica
accessLevelPublic
2011 1,036 593
Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticlesBioconjugate chemistry
accessLevelPrivate
2011 642 0
Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised childrenVaccine
accessLevelRestricted
2011 632 0
Challenges in infant immunity: implications for responses to infection and vaccinesNature immunology
accessLevelRestricted
2011 463 0
Vaccination during pregnancy to protect infants against influenza: why and why not?Vaccine
accessLevelRestricted
2011 601 0
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center studyArthritis and rheumatism
accessLevelRestricted
2011 859 8
Bulletin spécial semaine de la vaccination: rougeole avril no 4/2011 1Archives de pédiatrie
accessLevelRestricted
2011 408 0
De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipientsAmerican journal of transplantation
accessLevelRestricted
2011 653 0
ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemiaPharmacogenomics
accessLevelRestricted
2011 941 6
Neonatal immunization: where do we stand?Current opinion in infectious diseases
accessLevelRestricted
2011 506 2
Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition?Archives of neurology
accessLevelRestricted
2011 685 0
Bulletin InfoVac-FranceArchives de pédiatrie
accessLevelRestricted
2011 551 0
The next decade of vaccines: societal and scientific challengesLancet
accessLevelRestricted
2011 642 0
Immunity to pneumococcal surface proteins in children with community-acquired pneumonia: a distinct pattern of responses to pneumococcal choline-binding protein AClinical microbiology and infection
accessLevelRestricted
2011 624 0
Bulletin infovacArchives de pédiatrie
accessLevelRestricted
2011 546 0
Improvement of measles immunity among migrant populations: lessons learned from a prevalence study in a Swiss prisonSchweizerische medizinische Wochenschrift
accessLevelRestricted
2011 739 1
Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experienceAgeing research reviews
accessLevelPublic
2011 702 1,080
Actualités vaccinologiques suisses: nouveaux vaccins glycoconjugués contre pneumocoques et méningocoquesRevue médicale suisse
accessLevelRestricted
2011 476 1
Mode of action of adjuvants: implications for vaccine safety and designBiologicals
accessLevelRestricted
2010 624 0
Vaccinologie. Questions autour de la sécurité des vaccins adjuvantes contre la grippe A(H1N1)Revue médicale suisse
accessLevelRestricted
2010 505 1
Glycoconjugate vaccines and immune interference: A reviewVaccine
accessLevelRestricted
2010 535 0
Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunityNature medicine
accessLevelRestricted
2010 577 0
Frequent failure of adolescent booster responses to tetanus toxoid despite infant immunization: waning of infancy-induced immune memory?Vaccine
accessLevelRestricted
2010 572 0
Chickenpox in a Swiss prison: susceptibility, post-exposure vaccination and control measuresScandinavian journal of infectious diseases
accessLevelRestricted
2010 709 3
Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancyThe Journal of infectious diseases
accessLevelRestricted
2010 542 0
Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected childrenArchives of disease in childhood
accessLevelRestricted
2010 675 0
Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countriesMedicine
accessLevelRestricted
2010 596 1
Booster vaccination after neonatal priming with acellular pertussis vaccineThe Journal of pediatrics
accessLevelRestricted
2010 574 0
B-cell responses to vaccination at the extremes of ageNature reviews. Immunology
accessLevelRestricted
2009 583 0
Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trialsLancet
accessLevelRestricted
2009 659 0
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesLancet
accessLevelRestricted
2009 570 0
Impaired antibody response causes persistence of prototypic T cell-contained virusPLoS biology
accessLevelPublic
2009 739 703
Comment on "Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironment where plasmablasts mature"The Journal of immunology
accessLevelRestricted
2009 530 0
Vaccinologie : quel rattrapage pour les patients avec des vaccinations inconnues ou incomplètes ?Revue médicale suisse
accessLevelRestricted
2009 490 0
Interpretation of primary care physicians' attitude regarding rotavirus immunisation using diffusion of innovation theoriesVaccine
accessLevelRestricted
2009 652 0
Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelinesEuropean journal of pediatrics
accessLevelRestricted
2009 681 0
Immunization and transplantation--what is new and what is coming?Pediatric transplantation
accessLevelRestricted
2009 494 0
A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cellsPloS one
accessLevelPublic
2009 688 398
Allergies et vaccins : distinguer le vrai du fauxRevue médicale suisse
accessLevelRestricted
2009 491 0
Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in SwitzerlandThe Pediatric infectious disease journal
accessLevelRestricted
2009 676 0
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablastsBlood
accessLevelRestricted
2008 679 0
Recurrence of cardiorespiratory events following repeat DTaP-based combined immunization in very low birth weight premature infantsThe Journal of pediatrics
accessLevelRestricted
2008 583 0
The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster responseThe Journal of immunology
accessLevelRestricted
2008 590 2
Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected childrenThe Pediatric infectious disease journal
accessLevelRestricted
2008 631 3
Rougeole : diagnostic et prise en charge d'une maladie toujours d'actualitéRevue médicale suisse
accessLevelRestricted
2008 646 0
Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibodyClinical infectious diseases
accessLevelRestricted
2008 568 0
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cellsBlood
accessLevelRestricted
2008 658 0
Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunizationThe Journal of pediatrics
accessLevelRestricted
2008 573 1
Actualités vaccinologiques pour 2008: quoi de neuf en Suisse ?Revue médicale suisse
accessLevelRestricted
2008 476 0
Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cellsEuropean Journal of Immunology
accessLevelRestricted
2008 579 0
Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniaeVaccine
accessLevelRestricted
2008 640 1
Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvantPloS one
accessLevelPublic
2008 642 389
Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infantsThe Journal of pediatrics
accessLevelRestricted
2008 609 0
Autoimmune diseases after adolescent or adult immunization: what should we expect?CMAJ. Canadian Medical Association journal
accessLevelPublic
2007 521 247
Mechanisms underlying adverse reactions to vaccinesJournal of comparative pathology
accessLevelRestricted
2007 564 0
Vaccine-induced immunity in children after orthotopic liver transplantation: a 12-yr review of the Swiss national reference centerPediatric transplantation
accessLevelRestricted
2007 632 0
Proximal splenic artery embolization for blunt splenic injury: clinical, immunologic, and ultrasound-Doppler follow-upThe Journal of trauma
accessLevelRestricted
2007 513 0
Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005Vaccine
accessLevelRestricted
2007 482 0
Atorvastatin treatment and vaccination efficacyJournal of clinical pharmacology
accessLevelRestricted
2007 599 0
Influence of anesthesia on immune responses and its effect on vaccination in children: review of evidencePaediatric anaesthesia
accessLevelRestricted
2007 620 2
Author's reply [Vaccination and anesthesia]Paediatric anaesthesia
accessLevelRestricted
2007 534 0
Vaccination des patients souffrant de maladies chroniques du foieRevue médicale suisse
accessLevelRestricted
2007 482 2
The challenges of vaccine responses in early life: selected examplesJournal of comparative pathology
accessLevelRestricted
2007 554 0
Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cellsJournal of virology
accessLevelPublic
2007 563 416
Vaccinologie : Plan de vaccination suisse 2007 : première lectureRevue médicale suisse
accessLevelRestricted
2007 488 4
Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactionsThe Pediatric infectious disease journal
accessLevelRestricted
2007 517 0
Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?Clinical and vaccine immunology
accessLevelPublic
2006 716 472
Actualités vaccinologiques 2005 : nouvelle catégorie de recommandations pour une protection vaccinale optimaleRevue médicale suisse
accessLevelRestricted
2006 483 0
Enhanced chickenpox exanthema in vaccine injection siteScandinavian journal of infectious diseases
accessLevelRestricted
2006 489 0
Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twinsVaccine
accessLevelRestricted
2006 542 0
Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacyEuropean Journal of Immunology
accessLevelRestricted
2006 510 0
Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survivalThe Journal of immunology
accessLevelPublic
2006 593 320
Les vaccins sous haute surveillance : effets indésirables des vaccins : questions posée et réponses apportées par InfoVacArchives de pédiatrie
accessLevelRestricted
2006 493 1
B. Zinka et al., Unexplained cases of sudden infant death shortly after hexavalent vaccinationVaccine
accessLevelRestricted
2006 623 0
Effect of month of vaccine administration on antibody responses in The Gambia and PakistanTM & IH. Tropical medicine and international health
accessLevelRestricted
2006 540 0
Predominant influence of environmental determinants on the persistence and avidity maturation of antibody responses to vaccines in infantsThe Journal of infectious diseases
accessLevelPublic
2006 577 371
Immunisation of premature infantsArchives of disease in childhood
accessLevelRestricted
2006 487 0
VaccinologieRevue médicale suisse
accessLevelRestricted
2005 440 0
Die Folgen einer ungenügenden Herdimmunität bei «pädiatrischen» Infektionskrankheiten - Beispiel einer MasernepidemieTherapeutische Umschau
accessLevelRestricted
2005 654 0
How do physicians immunize their own children? Differences among pediatricians and nonpediatriciansPediatrics
accessLevelRestricted
2005 510 0
Can successful vaccines teach us how to induce efficient protective immune responses?Nature medicine
accessLevelRestricted
2005 566 0
Infections récurrentes des voies respiratoires inférieures de l'enfant : quand et comment les investiguer ?Revue médicale suisse
accessLevelRestricted
2005 567 0
Vaccine safety controversies and the future of vaccination programsThe Pediatric infectious disease journal
accessLevelRestricted
2005 628 0
La vaccinologie, une science neuve aux prises avec les croyancesRevue médicale suisse
accessLevelRestricted
2005 433 0
Les adjuvants vaccinaux et la myofasciite à macrophagesArchives de pédiatrie
accessLevelRestricted
2005 565 1
The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703FEMS immunology and medical microbiology
accessLevelPublic
2005 563 270
The advantage of mucosal immunization for polysaccharide-specific memory responses in early lifeEuropean Journal of Immunology
accessLevelRestricted
2005 425 0
Immunisation, immunomodulation et prévention des infections respiratoiresRevue médicale suisse
accessLevelRestricted
2005 476 0
A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine SafetyAmerican journal of public health
accessLevelPublic
2004 571 661
Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell typeVaccine
accessLevelRestricted
2004 682 0
Influence of complement C3 amount on IgG responses in early life: immunization with C3b-conjugated antigen increases murine neonatal antibody responsesVaccine
accessLevelRestricted
2004 563 0
Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine responseVaccine
accessLevelRestricted
2004 638 0
Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory eventsThe Journal of pediatrics
accessLevelRestricted
2004 523 0
Genetic regulation of immune responses to vaccines in early lifeGenes and immunity
accessLevelRestricted
2004 530 0
Safety and efficacy of immune-stimulating complex-based antigen delivery systems for neonatal immunisation against respiratory syncytial virus infectionMicrobes and infection
accessLevelRestricted
2004 538 0
Partial activation of neonatal CD11c+ dendritic cells and induction of adult-like CD8+ cytotoxic T cell responses by synthetic microspheresThe Journal of immunology
accessLevelPublic
2004 628 682
Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adultsVaccine
accessLevelRestricted
2004 547 0
Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand white x C57BL/6)F(1)-bcl-2 transgenic miceThe Journal of immunology
accessLevelRestricted
2004 585 0
Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeysThe American journal of tropical medicine and hygiene
accessLevelPublic
2004 954 1,128
Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinantsVaccine
accessLevelRestricted
2003 446 0
Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium)Vaccine
accessLevelRestricted
2003 544 0
CpG-motifs enhance initial and sustained primary tetanus-specific antibody secreting cell responses in spleen and bone marrow, but are more effective in adult than in neonatal miceVaccine
accessLevelRestricted
2003 625 0
CD4-independent protective cytotoxic T cells induced in early life by a non-replicative delivery system based on virus-like particlesVirology
accessLevelPublic
2003 592 339
Les adjuvants vaccinaux et la myofasciite à macrophagesBulletin de l'Académie nationale de médecine
accessLevelRestricted
2003 561 0
Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidateVaccine
accessLevelRestricted
2003 579 0
Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implicationsThe Journal of experimental medicine
accessLevelPublic
2003 507 883
Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigensThe Journal of immunology
accessLevelPublic
2003 539 469
Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothersThe Journal of immunology
accessLevelPublic
2003 587 520
Prévention vaccinale chez les adolescents : et s'il suffisait d'y penser ?Médecine et hygiène
accessLevelRestricted
2003 426 2
Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cellsThe Journal of immunology
accessLevelPublic
2002 562 277
Polémiques de sécurité vaccinale : fin d'une histoire ou histoire sans fin ?Médecine et hygiène
accessLevelRestricted
2002 369 0
Generation of adult-like antibody avidity profiles after early-life immunization with protein vaccinesEuropean Journal of Immunology
accessLevelRestricted
2002 549 2
Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal miceInfection and immunity
accessLevelPublic
2002 515 276
Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussisInfection and immunity
accessLevelPublic
2002 574 277
Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infectionThe Journal of infectious diseases
accessLevelRestricted
2002 569 0
Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccinationThe Journal of immunology
accessLevelPublic
2002 554 313
Epidemiology of herpes simplex virus in children by detection of specific antibodies in salivaThe Pediatric infectious disease journal
accessLevelRestricted
2001 541 0
Induction of adult-like antibody, Th1, and CTL responses to measles hemagglutinin by early life murine immunization with an attenuated vaccinia-derived NYVAC(K1L) viral vectorVirology
accessLevelPublic
2001 582 304
Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodiesFEMS immunology and medical microbiology
accessLevelPublic
2001 531 259
Neonatal and early life vaccinologyVaccine
accessLevelRestricted
2001 577 0
Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early lifeEuropean Journal of Immunology
accessLevelRestricted
2001 473 2
The search for novel adjuvants for early life vaccinations: can "danger" motifs show us the way?Archivum Immunologiae et Therapiae Experimentalis
accessLevelRestricted
2001 471 0
Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigensImmunology
accessLevelPublic
2001 592 515
Infections récidivantes de l'enfant : quel dépistage immunitaire ?Archives de pédiatrie
accessLevelRestricted
2001 473 0
Nosocomial outbreak of multiple bloodborne viral infectionsThe Journal of infectious diseases
accessLevelPublic
2001 668 241
How to improve communication on vaccine issues at the national level? INFOVAC-PED: an example from SwitzerlandVaccine
accessLevelRestricted
2001 513 0
Detection of enteroviruses in the cerebrospinal fluid by polymerase chain reaction: prospective study of impact on the management of hospitalized childrenClinical pediatrics
accessLevelRestricted
2000 609 0
Expression of MHC class II molecules contributes to lipopolysaccharide responsivenessEuropean Journal of Immunology
accessLevelRestricted
2000 460 0
Vaccin contre la fièvre jaune : formellement contre-indiqué chez les transplantésMédecine et hygiène
accessLevelRestricted
2000 448 0
A brief view of known landmarks reorientates path integration in hamstersNaturwissenschaften
accessLevelRestricted
2000 594 0
Non, le vaccin contre l'hépatite B ne provoque pas la sclérose en plaques : retour sur un psychodrame collectifLa Recherche
accessLevelRestricted
2000 548 1
Quand et comment vacciner les prématurés ?Médecine et hygiène
accessLevelRestricted
2000 385 0
Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in miceEuropean Journal of Immunology
accessLevelRestricted
1999 514 0
Antigen-Presentation Systems, Immunomodulators, and Immune Responses to VaccinesHandbook of experimental pharmacology
accessLevelRestricted
1999 372 0
Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussisLancet
accessLevelRestricted
1999 515 0
CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal primingThe Journal of immunology
accessLevelPublic
1999 476 215
Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study GroupAIDS
accessLevelRestricted
1998 456 0
Determinants of infant responses to vaccines in presence of maternal antibodiesVaccine
accessLevelRestricted
1998 470 0
Die Impfung gegen Hepatitis BSozial- und Präventivmedizin
accessLevelRestricted
1998 462 0
Quel avenir pour les vaccins ?Revue médicale de la Suisse romande
accessLevelRestricted
1998 458 0
Procalcitonin is a marker of severity of renal lesions in pyelonephritisPediatrics
accessLevelRestricted
1998 607 1
Hépatite B et sclérose en plaques : comment répondre aux inquiétudes du public ?Médecine et hygiène
accessLevelRestricted
1998 429 0
Influenza immunization: improving compliance of healthcare workersInfection control and hospital epidemiology
accessLevelRestricted
1998 512 0
Immunity in early lifeImmunology today
accessLevelRestricted
1998 479 0
New challenges for global immunizationSymposium in Immunology: Vol. VII : Vaccination
accessLevelRestricted
1998 471 0
Immunity in early life : an introduction [Proceedings of the International Symposium on Immunity in Early Life. Annecy, France, 17-19 November 1997]Vaccine
accessLevelRestricted
1998 474 0
Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells?Vaccine
accessLevelRestricted
1998 537 0
Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in miceEuropean Journal of Immunology
accessLevelRestricted
1998 553 0
Vaccination des sujets présentant un problème médical : précautions, contre-indicationsRevue médicale de la Suisse romande
accessLevelRestricted
1998 470 0
Optimization of vaccine responses in early life: the role of delivery systems and immunomodulatorsImmunology and cell biology
accessLevelPublic
1998 480 524
Maternal immunity and infant responses to immunization : actors influencing infant responsesPreclinical and clinical development of new vaccines : proceedings of a symposium, Institut Pasteur, Paris, France, 27-28 May 1997
accessLevelRestricted
1998 404 0
Les vaccins contre l'hépatite BSozial- und Präventivmedizin
accessLevelRestricted
1998 572 0
Le développement de nouveaux vaccins à usage pédiatrique : progrès et défisRevue médicale de la Suisse romande
accessLevelRestricted
1998 467 0
CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young miceProceedings of the National Academy of Sciences of the United States of America
accessLevelPublic
1998 566 695
Cervical lymphadenitis caused by Mycobacterium genavense in a healthy childThe Pediatric infectious disease journal
1996 641 0
Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promotersThe Journal of biological chemistry
accessLevelRestricted
1994 608 0
Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-YProceedings of the National Academy of Sciences of the United States of America
accessLevelRestricted
1994 588 0
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancerMolecular and cellular biology
accessLevelRestricted
1993 590 0
Septicémie à anaérobes après infections oropharyngées (septicémie post-angine de Lemierre): un syndrome oubliéSchweizerische medizinische Wochenschrift
1983 744 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack